FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications
The federal agency is requiring all GLP-1s to include information about the potential risk on warning labels The US Food and Drug Administration (FDA) has issued a new warning on GLP-1 medications…
The Guardian
Full text, translation and AI summary — after signing in
- The full article in your language
- AI summary and translation from the original
- The same account works in the Suviy app
Related coverage
Comments
Sign in to join the conversation. Sign in
No comments yet.